Status
Conditions
Treatments
About
CPETecho is progressively employed in diagnostic settings for pathophysiological detection, offering comprehensive assessment of both pulmonary and cardiac functions. This technique evolves from its invasive counterpart, where a diagnostic catheter is employed for hemodynamic monitoring, by substituting the invasive component with non-invasive echocardiography. Nevertheless, data on the test-retest reliability of CPETecho remain sparse, a factor critical in differentiating between measurement effects and actual therapeutic impacts.
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
- Unstable symptoms, whereby therapy cannot be delayed for a week.
Primary purpose
Allocation
Interventional model
Masking
30 participants in 1 patient group
Loading...
Central trial contact
Philippe Bertrand, MD, PhD; Sebastiaan Dhont, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal